Status:
RECRUITING
Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment
Lead Sponsor:
University Medicine Greifswald
Collaborating Sponsors:
University of Greifswald
Conditions:
Breast Cancer
Cognitive Impairment
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to investigate whether a high definition tDCS-accompanied intensive cognitive training of working memory leads to performance improvement in women with post-chemotherapy cogni...
Detailed Description
Patients who have undergone chemotherapy, may develop post-chemotherapy cognitive impairment (PCCI), which may occur in several cognitive domains and persist for many years. These declines in cognitiv...
Eligibility Criteria
Inclusion
- Chemotherapy to treat breast cancer (≥ 6 months post-treatment).
- Self-reported concerns regarding cognitive functioning.
- Age: 18-65 years.
- right-handedness
Exclusion
- History of dementia before treatment of cancer.
- Other neurodegenerative neurological disorders; epilepsy or history of seizures.
- Severe and untreated medical conditions that preclude participation in the training, as determined by responsible physician.
- History of moderate to severe substance use disorder according to DSM-5
- Moderate to severe acute psychiatric disorders according to DSM-5
- Contraindication to tDCS application (Antal et al., 2017)
Key Trial Info
Start Date :
November 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04817566
Start Date
November 2 2021
End Date
June 1 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medicine Greifswald
Greifswald, Germany